This inventor holds 1 USPTO granted patent. Top assignee: Genetic Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Marcelo Nicolas Muscara′: Innovator in Pharmaceutical Compositions
Introduction
Marcelo Nicolas Muscara′ is a notable inventor based in Campinas, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for respiratory diseases. His work focuses on enhancing the efficacy of existing medications through novel formulations.
Latest Patents
Muscara′ holds a patent for "Montelukast esters and pharmaceutical compositions containing the same." This invention pertains to esters of Montelukast combined with corticosteroids, such as des-ciclesonide, triamcinolone, budesonide, or flunisolide. The pharmaceutical compositions developed from this invention are aimed at treating various respiratory tract diseases, including asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. The patent also details the process for preparing these esters, showcasing Muscara′'s innovative approach to pharmaceutical development.
Career Highlights
Muscara′ is associated with Genetic S.p.a., where he continues to advance his research and development efforts. His work has not only contributed to the scientific community but has also provided new therapeutic options for patients suffering from respiratory conditions.
Collaborations
Muscara′ has collaborated with esteemed colleagues, including Giuseppe Caliendo and Giuseppe Cirino. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective pharmaceutical solutions.
Conclusion
Marcelo Nicolas Muscara′ exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of respiratory treatments, highlight the importance of research and collaboration in developing effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile